Bone Biologics BBLG
NASDAQ BBLG
$0.39 +0.00 (+0.43%)
As of: Oct 23, 2026 · 3:59 PM EDT

Bone Biologics (BBLG) Return on Sales [ROS] (2023 - 2024)

Updated

Bone Biologics (BBLG) posted Return on Sales [ROS] of -1.91% for FY2016.

Analysis

Bone Biologics (BBLG) Return on Sales [ROS] (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 250.13 Bn 229.16 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 180.31 Bn 150.74 Bn 7.27 Bn 13.44%
3 Danaher 162.34 Bn 146.15 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 158.13 Bn 138.42 Bn 2.08 Bn 19.44%
5 Medtronic 122.37 Bn 87.63 Bn 6.34 Bn 18.08%
6 Stryker 117.89 Bn 104.00 Bn 4.50 Bn 25.18%
7 Boston Scientific 67.15 Bn 61.92 Bn 3.85 Bn 21.65%
8 Becton Dickinson 54.68 Bn 51.83 Bn 2.32 Bn 13.31%
9 Edwards Lifesciences 51.43 Bn 35.44 Bn 1.35 Bn 29.48%
10 Bone Biologics 709,358.89 -21.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -354,327.84%
Dec 31, 2023 -332,380.52%
Sep 30, 2023 -388,225.75%
Jun 30, 2023 -710,249.53%
Mar 31, 2023 -566,103.78%
API Access

Bone Biologics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BBLG&period=max&api_key=YOUR_API_KEY